中华病理学杂志
中華病理學雜誌
중화병이학잡지
Chinese Journal of Pathology
2014年
6期
394-398
,共5页
刘晓红%曹永成%王翠翠%曹瑞雪%陈鑫%丁吉远%耿明
劉曉紅%曹永成%王翠翠%曹瑞雪%陳鑫%丁吉遠%耿明
류효홍%조영성%왕취취%조서설%진흠%정길원%경명
结直肠肿瘤,遗传性非息肉性%聚合酶链反应%免疫组织化学
結直腸腫瘤,遺傳性非息肉性%聚閤酶鏈反應%免疫組織化學
결직장종류,유전성비식육성%취합매련반응%면역조직화학
Colorectal neoplasms,hereditary nonpolyposis%Polymerase chain reaction%Immunohistochemistry
目的 探讨错配修复基因(MMR)蛋白的检测对Lynch综合征相关结直肠癌患者进行初步筛查的作用.方法 收集2012至2013年间100例连续的结直肠癌病例,采用免疫组织化学EnVision法检测MLH1、MSH2、MSH6和PMS2蛋白的表达,借助扩增阻滞突变系统(ARMS)方法检测MLH1蛋白失表达病例BRAF基因的突变状态.结果 免疫组织化学结果显示9% (9/100)的病例出现MMR蛋白缺失表达,其中MLH1-/PMS2-和MSH2-/MSH6-者各3例,2例MLH6-,PMS2-者为1例,以MLH1和MSH2蛋白缺失表达为主.BRAF基因突变检测,证实1例患者存在突变,提示该患者可能存在因BRAF基因突变导致的MLH1基因甲基化,为散发性病例.MMR蛋白缺失表达患者发病年龄低于散发性结肠癌患者(P=0.011),多发生于右半结肠(P=0.001),组织形态学上常伴黏液腺癌分化(P=0.010)及肿瘤间淋巴细胞浸润.结论 对结直肠癌患者进行MMR蛋白的免疫组织化学染色,结合BRAF基因的突变检测,是初步筛查Lynch综合征的有效策略.
目的 探討錯配脩複基因(MMR)蛋白的檢測對Lynch綜閤徵相關結直腸癌患者進行初步篩查的作用.方法 收集2012至2013年間100例連續的結直腸癌病例,採用免疫組織化學EnVision法檢測MLH1、MSH2、MSH6和PMS2蛋白的錶達,藉助擴增阻滯突變繫統(ARMS)方法檢測MLH1蛋白失錶達病例BRAF基因的突變狀態.結果 免疫組織化學結果顯示9% (9/100)的病例齣現MMR蛋白缺失錶達,其中MLH1-/PMS2-和MSH2-/MSH6-者各3例,2例MLH6-,PMS2-者為1例,以MLH1和MSH2蛋白缺失錶達為主.BRAF基因突變檢測,證實1例患者存在突變,提示該患者可能存在因BRAF基因突變導緻的MLH1基因甲基化,為散髮性病例.MMR蛋白缺失錶達患者髮病年齡低于散髮性結腸癌患者(P=0.011),多髮生于右半結腸(P=0.001),組織形態學上常伴黏液腺癌分化(P=0.010)及腫瘤間淋巴細胞浸潤.結論 對結直腸癌患者進行MMR蛋白的免疫組織化學染色,結閤BRAF基因的突變檢測,是初步篩查Lynch綜閤徵的有效策略.
목적 탐토착배수복기인(MMR)단백적검측대Lynch종합정상관결직장암환자진행초보사사적작용.방법 수집2012지2013년간100례련속적결직장암병례,채용면역조직화학EnVision법검측MLH1、MSH2、MSH6화PMS2단백적표체,차조확증조체돌변계통(ARMS)방법검측MLH1단백실표체병례BRAF기인적돌변상태.결과 면역조직화학결과현시9% (9/100)적병례출현MMR단백결실표체,기중MLH1-/PMS2-화MSH2-/MSH6-자각3례,2례MLH6-,PMS2-자위1례,이MLH1화MSH2단백결실표체위주.BRAF기인돌변검측,증실1례환자존재돌변,제시해환자가능존재인BRAF기인돌변도치적MLH1기인갑기화,위산발성병례.MMR단백결실표체환자발병년령저우산발성결장암환자(P=0.011),다발생우우반결장(P=0.001),조직형태학상상반점액선암분화(P=0.010)급종류간림파세포침윤.결론 대결직장암환자진행MMR단백적면역조직화학염색,결합BRAF기인적돌변검측,시초보사사Lynch종합정적유효책략.
Objective To evaluate the application of mismatch repair (MMR) genes proteins expression to screen for Lynch syndrome in colorectal cancer patients.Methods One hundred consecutive colorectal cancers cases collected from 2012 to 2013 were tested immunohistochemically for the protein expression of MLH1,MSH2,MSH6 and PMS2,and also by the ARMS method for the mutation status of BRAF genes in those cases lacking protein expression for MLH1.Results The result of MMR immunocytochemistry showed that nine of 100 cases lacked MMR protein expression,including three cases each that were MLH1-/PMS2-and MSH2-/MSH6-respectively,two cases were MLH6-and one case was PMS2-; overall,the majority of these cases lacked protein expression of MLH1 and MSH2.The BRAF genes mutation test showed one case of mutation,indicating that the patient might have MLH1 gene methylation as a result of the mutation of BRAF genes,and that was a sporadic case.The age of onset for patients lacking MMR protein expression was lower than patients with sporadic colorectal cancer (P =0.011).Colorectal cancers associated with the lack of MMR protein expression mostly occurred in the right colon (P =0.001),and histomorphologically were often accompanied by mucinous adenocarcinoma (P =0.010) and tumor lymphocytic irnfiltration.Conclusion Immunohistochemical staining for MMR proteins in patients with colorectal cancer,accompanied by testing for BRAF genes mutation,may be an effective approach to screen for Lynch syndrome.